title: Halothane, isoflurane and sevoflurane in pediatric anesthesia: can we decrease costs without increasing adverse events?
authors.forename: Alejandro A
authors.initials: AA
authors.lastname: Nava-Ocampo
authors.forename: Juan M
authors.initials: JM
authors.lastname: Alarcón-Almanza
authors.forename: Diana
authors.initials: D
authors.lastname: Moyao-García
authors.forename: Juan C
authors.initials: JC
authors.lastname: Ramírez-Mora
authors.forename: Jorge
authors.initials: J
authors.lastname: Salmerón
mesh_terms: D000769:Anesthesia, Inhalation / Q000009:adverse effects* / Q000191:economics*; D018685:Anesthetics, Inhalation / Q000009:adverse effects* / Q000191:economics*; D002648:Child; D016527:Drug Costs; D006221:Halothane / Q000009:adverse effects* / Q000191:economics*; D006801:Humans; D007530:Isoflurane / Q000009:adverse effects* / Q000191:economics*; D008738:Methyl Ethers / Q000009:adverse effects* / Q000191:economics*; D008800:Mexico; D000077149:Sevoflurane
chemical_list: D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D000077149:Sevoflurane; D007530:Isoflurane; D006221:Halothane